Related Experiment Video
Updated: Sep 21, 2025

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
[Prevention of venous thromboembolism in patients with cancer]
Florence Parent1, Mariana Preda1, Andrei Seferian1
1Service de pneumologie et soins intensifs respiratoires, hôpital Bicêtre, AP-HP, Inserm UMR_S 999, Le Kremlin-Bicêtre, France.
Abstract:
"Prevention of venous thromboembolism in patients with cancer Risk of venous thromboembolism (vte) is elevated in cancer and leads to high mor¬bidity and mortality in this population. Drug prophylaxis is questionable, due hemor¬rhagic risk in these patients, and explains the importance of selecting high risk popu¬lation, depending on the type of cancer and on individual risk factors for thrombosis. While the indications for prevention are well established during hospitalization for an acute condition and during cancer surgery, mostly with low molecular weight heparin, questions persist as to the indication of prophylaxis for outpatients receiving chemo¬therapy, and to the place of direct oral anticoagulant in this indication."
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism III: Nursing Management
Venous Thrombosis I: Introduction
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

